Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles

References

Page 1

	Year	Citations
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao, Cell Regenerative MedicineEpithelial-mesenchymal TransitionDevelopmental BiologyMedicineAdult Stem Cell	2008	8.6K
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening Piyush B. Gupta, Tamer T. Önder, Guozhi Jiang, Cell Hit IdentificationCancer GenomicsStem Cell ResearchSelective InhibitorsAnti-cancer Agent	2009	2.4K
MicroRNAs in cell proliferation, cell death, and tumorigenesis Hun‐Way Hwang, Joshua T. Mendell British Journal of Cancer	2006	1.4K
Drug Delivery with Carbon Nanotubes for <i>In vivo</i> Cancer Treatment Zhuang Liu, Kai Chen, Corrine R. Davis, Cancer Research NanoparticlesNanotherapeuticsEngineeringWater-soluble Swnt-ptx ConjugateBiomedical Engineering	2008	1.3K
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells Yohei Shimono, Maider Zabala, Robert W. Cho, Cell MedicineStem Cell ResearchNormal Stem CellsBreast CancerLong Non-coding Rna	2009	1.2K
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 Shigeo Takaishi, Tomoyuki Okumura, Shuiping Tu, Stem Cells Tumor BiologyLineage PlasticityGastric Cancer CellsGastric CscsMedicine	2009	1K
Up-regulation of <i>miR-200</i> and <i>let-7</i> by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells Yiwei Li, Timothy VandenBoom, Dejuan Kong, Cancer Research	2009	656
Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer Yong Wang, Shujun Gao, Wenhui Ye, Nature Materials NanoparticlesNanomedicineEngineeringBiodegradable CopolymerPolymer-drug Conjugate	2006	651
The CD44+/CD24-phenotype is enriched in basal-like breast tumors Gabriella Honeth, Pär‐Ola Bendahl, Markus Ringnér, Breast Cancer Research	2008	551
Genetic heterogeneity and cancer drug resistance Nicholas C. Turner, Jorge S. Reis‐Filho The Lancet Oncology Tumor BiologyMedicineResistance Mutation (Virology)PharmacogenomicsGenetic Heterogeneity	2012	447

Page 1